Mural Oncology plc (MURA) NASDAQ

Currency In USD

AD

Mural Oncology plc

Address

10 Earlsfort Terrace

Dublin, D02 T380

Ireland

Phone

353 1 905 8020

Sector

Healthcare

Industry

Biotechnology

Employees

116

First IPO Date

November 16, 2023

Key Executives

NameTitlePayYear Born
Caroline J. LoewPresident, Chief Executive Officer & Director1.01M1971
Adam D. CutlerChief Financial Officer, Principal Financial Officer & Principal Accounting Officer735,2501974
Vicki L. GoodmanChief Medical Officer987,2501970
Justin LevineHead of Human Resources & Vice President of Human Resources0N/A
Maiken Keson-BrookesChief Legal Officer01973
AD

Description

Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.

AD